UPTAKE AND ACTION OF A DISULPHONIC STILBENE (SITS) IN THE PERFUSED GUINEA-PIG LIVER: A COMPARISON WITH BROMSULPHTHALEINRUTISHAUSER SCB.1983; JOURNAL OF PHYSIOLOGY; ISSN 0022-3751; GBR; DA. 1983; VOL. 334; PP. 505-518; BIBL. 2 P.Article

L'antithrombine III = Antithrombin IIIMASSIGNON, D.Lyon pharmaceutique. 1985, Vol 36, Num 1, pp 5-11, issn 0024-7804Article

GESAMTES UND AKTIVIERTES ANTITHROMBIN III: WIRKUNG UND NACHWEIS = ANTITHROMBINE III TOTALE ET ACTIVEE: EFFET ET MISE EN EVIDENCEROKA L; BLEYL H.1979; Z. MED. LAB.-DIAGNOST.; DDR; DA. 1979; VOL. 20; NO 2; PP. 68-77; ABS. RUS/ENG; BIBL. 3 REF.Article

Biodistribution of covalent antithrombin-heparin complexesCHINDEMI, Paul A; KLEMENT, Petr; KONECNY, Filip et al.Thrombosis and haemostasis. 2006, Vol 95, Num 4, pp 629-636, issn 0340-6245, 8 p.Article

A NEW FAMILIAL VARIANT OF ANTITHROMBIN. III: ANTITHROMBINE III PARIS'WOLF M; BOYER C; LAVERGNE JM et al.1982; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1982; VOL. 51; NO 2; PP. 285-295; BIBL. 35 REF.Article

ANTITHROMBINE PLASMATIQUE ET SERIQUE: METHODOLOGIE ET APPLICATIONS CLINIQUESCONARD JACQUELINE.1981; ; FRA; DA. 1981; 207 P.-PL.; 30 CM; BIBL. 25 P.; TH.: SCI. PHARM./PARIS 5/1981/58Thesis

Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reactionPERRY, D. J; HARPER, P. L; FAIRHAM, S et al.FEBS letters. 1989, Vol 254, Num 1-2, pp 174-176, issn 0014-5793, 3 p.Article

DEFICITS CONSTITUTIONNELS ET ACQUIS EN ANTITHROMBINE III: A PROPOS DE DEUX OBSERVATIONSLAHARRAGUE P; CAUSSE B; BOUISSOU F et al.1980; REV. MED. TOULOUSE; FRA; DA. 1980; VOL. 16; NO 4; PP. 201-205; (4 P.); ABS. ENG; BIBL. 16 REF.Article

Antithrombin : Early prophecies and present challengesABILDGAARD, Ulrich.Thrombosis and haemostasis. 2007, Vol 98, Num 1, pp 97-104, issn 0340-6245, 8 p.Article

Dysfunctional antithrombin III in sick premature infantsANDREW, M; MASSICOTTE-NOLAN, P; MITCHELL, L et al.Pediatric research. 1985, Vol 19, Num 2, pp 237-239, issn 0031-3998Article

Antithrombin Glasgow, 393 Arg to His: a P₁ reactive site variant with increased heparin affinity but no thrombin inhibitory activityOWEN, M. C; BERESFORD, C. H; CARRELL, R. W et al.FEBS letters. 1988, Vol 231, Num 2, pp 317-320, issn 0014-5793Article

ANTITHROMBIN III (AT III) PADUA₂: A "NEW" CONGENITAL ABNORMALITY WITH DEFECTIVE HEPARIN CO-FACTOR ACTIVITIES BUT NO THROMBOTIC DISEASEGIROLAMI A; FABRIS F; CAPPELLATO G et al.1983; BLUT; ISSN 0006-5242; DEU; DA. 1983; VOL. 47; NO 2; PP. 93-103; BIBL. 31 REF.Article

AT III CONTENT AND ANTITHROMBIN ACTIVITY IN OESTROGEN-PROGESTOGEN AND PROGESTOGEN-ONLY TREATED WOMENCONARD J; CAZENAVE B; SAMAMA M et al.1980; THROMBOSIS RES.; GBR; DA. 1980; VOL. 18; NO 5; PP. 675-681; BIBL. 17 REF.Article

Antithrombin Affects Hemostatic Response to Recombinant Activated Factor VII in Factor VIII Deficient PlasmaSZLAM, Fania; TAKETOMI, Taro; SHEPPARD, Chelsea A et al.Anesthesia and analgesia. 2008, Vol 106, Num 3, pp 719-724, issn 0003-2999, 6 p.Article

Conformation of the pentasaccharide corresponding to the binding site of heparin to antithrombin-IIIRAGAZZI, M; FERRO, D. R; PERLY, B et al.Carbohydrate research. 1987, Vol 165, Num 1, pp C1-C5, issn 0008-6215Article

PREGNANCY IN WOMEN WITH CONGENITAL ANTITHROMBIN III DEFICIENCY. EXPERIENCE OF TREATMENT WITH HEPARIN AND ANTITHROMBINHELLGREN M; TENGBORN L; ABILDGAARD U et al.1982; GYNECOL. OBSTET. INVEST.; ISSN 0378-7346; CHE; DA. 1982; VOL. 14; NO 2; PP. 127-141; BIBL. 31 REF.Article

CORRELATION OF IN VIVO AND IN VITRO INHIBITION OF THROMBIN BY PLASMA INHIBITORSVOGEL CN; KINGDON HS; LUNDBLAT RL et al.1979; J. LAB. CLIN. MED.; USA; DA. 1979; VOL. 93; NO 4; PP. 661-673; BIBL. 36 REF.Article

Antithrombins : their potential as antithrombotic agentsWEITZ, J. I; HIRSH, J.Annual review of medicine. 1992, Vol 43, pp 9-16, issn 0066-4219Article

An abnormal plasma antithrombin with no apparent affinity for heparinCHASSE, J. F; ESNARD, F; GUITTON, J. D et al.Thrombosis research. 1984, Vol 34, Num 4, pp 297-302, issn 0049-3848Article

The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activationNIELSEN, Vance G; LYERLY, Ralph T; GURLEY, William Q et al.Anesthesia and analgesia. 2004, Vol 99, Num 6, pp 1587-1592, issn 0003-2999, 6 p.Article

Antithrombin III and arterial diseaseCORTELLARO, M.Lancet (British edition). 1991, Num 8781, pp 1525-1526, issn 0140-6736Article

Isolation and characterization of a hereditary abnormal untithrombin III Antithrombin III ToyamäKOIDE, T; TAKAHASHI, K; ODANI, S et al.Thrombosis research. 1983, Vol 31, Num 2, pp 319-328, issn 0049-3848Article

Studies of the heterogeneity of antithrombin III concentratesBARROWCLIFFE, T. W; EGGLETON, C. A; MAHMOUD, M et al.British journal of haematology. 1983, Vol 55, Num 1, pp 37-46, issn 0007-1048Article

The impact of total parenteral nutrition on antithrombin IIINEHME, A. E; BOYD, M. C.JPEN. Journal of parenteral and enteral nutrition. 1983, Vol 7, Num 6, pp 573-574, issn 0148-6071Article

Evaluation of Antimicrobial, Antioxidant, and Antithrombin Activity of Domestic Fruit and VegetableLEE, Man-Hyo; KIM, Mi-Sun; SHIN, Hwa-Gyun et al.Han'gug mi'saengmul saengmyeong gong haghoeji. 2011, Vol 39, Num 2, pp 146-152, issn 1598-642X, 7 p.Article